In Lisbon, ESC Preventive Cardiology 2025 brings together experts dedicated to enhancing preventive measures in cardiology. Attendees will gain insights into evidence-based approaches, community health strategies, and innovative technologies improving patient outcomes. Our team will present research addressing key challenges in prevention and discuss collaboration opportunities to drive impactful solutions. Let’s meet to explore shared goals in advancing preventive care.
Medicines Marketing UK / EU vs US: Why Your Launch Strategy Needs a Continental Divide - Dr Lisa Campbell, Director of Regulatory Strategy
September 12, 2025
A UK CRO’s perspective on planning clinical trials for global success For pharmaceutical companies preparing for global expansion, launching in both the US and EU / UK markets often seems like the natural next step. Yet success in one region does not guarantee success in the other.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.